EMPLOYMENT AGREEMENT for ERIC ADLER, M.D.Employment Agreement • April 9th, 2024 • Lexeo Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledApril 9th, 2024 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made between Lexeo Therapeutics, Inc. (the “Company”) and Eric Adler, M.D. (the “Executive”) (collectively, the “Parties”).
Center for Technology Licensing 1155 York Avenue New York, NY 10065 P: 646.962.7045 innovation.weill.cornell.eduLicense Agreement • April 9th, 2024 • Lexeo Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledApril 9th, 2024 Company Industryto the FIRST LICENSE AGREEMENT by and between Lexeo Therapeutics, Inc. (hereinafter “Licensee”) and Cornell University (“Cornell”) (each a “Party”) effective May 28, 2020 and amended a first time effective July 4, 2022 and a second time effective September 28, 2022 (Cornell Contract C2020-11-13204) (the “First License Agreement”)